(S (NP-SBJ (NP (NN G-LRB-Anh-RRB-MTetra)) (, ,) (NP (DT a) (JJ natural) (JJ bacterial) (NN cell) (NN wall) (NN breakdown) (NN product)) (, ,)) (VP (VBZ induces) (NP (NP (NP-COOD (NP (NN interleukin-1) (NN beta)) (CC and) (NP (NN interleukin-6))) (NN expression)) (PP (IN in) (NP (JJ human) (NNS monocytes))))) (. .))
(NP (NP (DT A) (NN study)) (PP (IN of) (NP (NP (DT the) (JJ molecular) (NNS mechanisms)) (VP (VBN involved) (NP (-NONE- *)) (PP (IN in) (NP (JJ inflammatory) (NN cytokine) (NN expression)))))) (PRN (-LRB- -LCB-) (S (NP-SBJ (VBN published) (NN erratum)) (VP (VBZ appears) (PP (IN in) (NP (NP (NNP J) (NNP Biol) (NNP Chem)) (NP-TMP (CD 1994) (NNP Jun) (CD 17)) (: ;) (NP (CD 269) (-LRB- -LRB-) (CD 24) (-RRB- -RRB-)) (: :) (NP (CD 16983)))))) (-RRB- -RCB-)))
(S (NP-SBJ (PRP It)) (VP (VBZ is) (VP (VBN believed) (SBAR (IN that) (S (NP-SBJ (NP (NN induction)) (PP (IN of) (NP (NN cytokine) (NN expression))) (PP (IN by) (NP (JJ bacterial) (NN cell) (NN wall) (NNS components)))) (VP (VBZ plays) (NP (DT a) (NN role)) (PP (IN in) (NP (NP (DT the) (NP-COOD (NP (NN development)) (CC and) (NP (NN course)))) (PP (IN of) (NP (NN sepsis)))))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP-SBJ-1 (JJS most) (NN attention)) (VP (VBZ has) (VP (VBN been) (VP (VBN focused) (NP (-NONE- *-1)) (PP (IN on) (NP (NP (NN lipopolysaccharide)) (PRN (-LRB- -LRB-) (NP (NN LPS)) (-RRB- -RRB-))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBD studied) (NP (NP (DT the) (NN ability) (S (-NONE- *ICH*-4))) (PP (IN of) (NP (NP (NP (NN N-acetylglucosaminyl-1,6-anhydro-N-acetylmuramyl-L-alanyl-D-isoglutamyl-m-diaminopimelyl-D-alanine)) (PRN (-LRB- -LRB-) (NP (NN G-LRB-Anh-RRB-MTetra)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (ADJP (RB naturally) (VBG occurring)) (NN breakdown) (NN product)) (PP (IN of) (NP (NN peptidoglycan))) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-3 (-NONE- *T*-2)) (VP (VBZ is) (VP (VBN produced) (NP (-NONE- *-3)) (PP (IN by) (NP-LGS (NP (JJ soluble) (JJ lytic) (NN transglycosylase)) (PP (IN of) (NP (FW Escherichia) (FW coli)))))))))) (, ,))) (S-4 (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB induce) (NP (NP (NN cytokine) (NN expression)) (PP (IN in) (NP (JJ human) (NNS monocytes))))))))) (. .))
(S (NP-SBJ-5 (NN G-LRB-Anh-RRB-MTetra)) (VP (VBD was) (VP (VBN found) (S (NP-SBJ (-NONE- *-5)) (VP (TO to) (ADVP (RB strongly)) (VP (VP-COOD (VP (VB induce) (NP-100 (NP-COOD (NP (NN interleukin) (-LRB- -LRB-) (NN IL) (-RRB- -RRB-) (CD -1) (NN beta)) (CC and) (NP (NN IL-6))) (NN mRNA) (NN expression)) (PP-TMP-101 (IN after) (NP (NP (CD 2) (NN h)) (PP (-NONE- *RNR*-102))))) (CC and) (VP (NP=100 (NP-COOD (NP (NN IL-1) (NN beta)) (CC and) (NP (NN IL-6))) (NN protein) (NN secretion)) (PP-TMP=101 (IN after) (NP (NP (CD 48) (NN h)) (PP (-NONE- *RNR*-102)))))) (PP-102 (IN of) (NP (NN activation)))))))) (. .))
(S (NP-SBJ-6 (NP (DT The) (NN increase)) (PP (IN in) (NP (NN mRNA) (NN accumulation)))) (VP-COOD (VP (VBD was) (PP-PRD (ADVP (ADVP (IN at) (JJS least)) (RB partly)) (JJ due) (TO to) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN transcription) (NNS rates)) (PP (IN of) (NP (DT the) (JJ respective) (NNS genes)))))))) (CC and) (VP (VBD was) (VP (VBN accompanied) (NP (-NONE- *-6)) (PP (IN by) (NP-LGS (NP (DT a) (JJ strong) (NN induction)) (PP (IN of) (NP (NP-COOD (NP (JJ nuclear) (NN factor-kappa) (NN B)) (CC and) (NP (NN activator) (NN protein-1) (NN transcription) (NN factor))) (NN expression)))))))) (. .))
(S (NP-SBJ (NP (NNS Experiments)) (VP (VBG using) (NP (NP (NNS inhibitors)) (PP (IN of) (NP-COOD (NP (NN protein) (NN kinase) (NN C)) (, ,) (NP (NN protein) (NN kinase) (NN A)) (, ,) (CC and) (NP (ADJP (NN tyrosine) (JJ kinase-dependent)) (NNS pathways))))))) (VP (VBD revealed) (SBAR (IN that) (S (NP-SBJ (JJ G-LRB-Anh-RRB-MTetra-induced) (NP-COOD (NP (NN IL-1) (NN beta)) (CC and) (NP (NN IL-6))) (NN mRNA) (NN expression)) (VP (VBZ involves) (NP (NP (NN activation)) (PP (IN of) (NP (DT an) (JJ H7-inhibitable) (NN pathway)))))))) (. .))
(S (PP (IN By) (S (NP-SBJ (-NONE- *)) (VP (VBG using) (NP (DT the) (NN protein) (NN synthesis) (NN inhibitor) (NN cycloheximide))))) (, ,) (S (NP-SBJ (PRP it)) (VP (VBD was) (VP (VBN shown) (SBAR (IN that) (S-COOD (S (NP-SBJ (JJ G-LRB-Anh-RRB-MTetra-induced) (NN IL-6) (NN mRNA) (NN expression)) (VP (VBZ depends) (PP (IN on) (NP (NP (DT the) (NN synthesis)) (PP (IN of) (NP (JJ new) (NN protein))))))) (, ,) (IN whereas) (S (NP-SBJ (JJ G-LRB-Anh-RRB-MTetra-induced) (NN IL-1) (NN beta) (NN mRNA) (NN accumulation)) (VP (VBZ does) (RB not) (VP (-NONE- *?*))))))))) (. .))
(S (SBAR-TMP (WHADVP-7 (WRB When)) (S (NP-SBJ-8 (NP (NNS responses)) (PP (TO to) (NP (NN G-LRB-Anh-RRB-MTetra)))) (VP (VBD were) (VP (VBN compared) (NP (-NONE- *-8)) (PP (IN with) (NP (NP (DT those)) (PP (TO to) (NP-COOD (NP (NN LPS)) (CC and) (NP (NP (NN muramyldipeptide)) (PRN (-LRB- -LRB-) (NP (NN MDP)) (-RRB- -RRB-))))))) (ADVP (-NONE- *T*-7)))))) (, ,) (NP-SBJ (PRP it)) (VP (VBD was) (VP (VBN found) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (JJ optimal) (NN response)) (PP (TO to) (NP (NN G-LRB-Anh-RRB-MTetra) (NN induction)))) (VP (VBD was) (ADJP-PRD-COOD (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (PP (IN of) (NP (NN LPS)))))) (CC but) (ADJP (ADJP (RB significantly) (JJR higher)) (PP (IN than) (NP (NP (DT the) (NN response)) (PP (TO to) (NP (NN MDP)))))))))))) (. .))
(S (ADVP (RB Furthermore)) (, ,) (NP-SBJ-9 (JJ maximal) (JJ G-LRB-Anh-RRB-MTetra-induced) (NP-COOD (NP (NN IL-1) (NN beta)) (CC and) (NP (NN IL-6))) (NN mRNA) (NN expression)) (VP (MD could) (VP (VB be) (VP (VBN enhanced) (NP (-NONE- *-9)) (PP (IN by) (NP-LGS (NP (NN co-stimulation)) (PP (IN with) (NP-COOD (NP (NN LPS)) (CC or) (NP (NN MDP)))))) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ-11 (JJ different) (NP-COOD (NP (NNS receptors)) (CC (or and)) (NP (NN transduction) (NNS pathways)))) (VP (VBD were) (VP (VBN involved) (NP (-NONE- *-11))))))))))) (. .))
(S (NP-SBJ (DT These) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP-SBJ (NN G-LRB-Anh-RRB-MTetra)) (VP (VBZ induces) (NP (NP (NP-COOD (NP (NN IL-1) (NN beta)) (CC and) (NP (NN IL-6))) (NN expression)) (PP (IN in) (NP (JJ human) (NNS monocytes)))) (S (NP-SBJ (-NONE- *)) (VP (VBG suggesting) (NP (NP (DT a) (JJ possible) (NN role)) (PP (IN for) (NP (NN G-LRB-Anh-RRB-MTetra))) (PP (IN in) (NP (NP (DT the) (NN release)) (PP (IN of) (NP (NNS cytokines))) (PP-TMP (IN during) (NP (NN sepsis)))))))))))) (. .))
